Antibodies Causing Epilepsy Syndromes: The ACES Study.
NCT02802475 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 582
Last updated 2022-07-28
Summary
The Antibodies Causing Epilepsy Syndromes (ACES) Study is a observational cohort study focusing on detection of auto-immune epilepsy in patients with epilepsy of unknown origin.
Conditions
- Auto-immune Encephalitis
- Epilepsy
Interventions
- BIOLOGICAL
-
vena punction
Sponsors & Collaborators
-
Nationaal Epilepsie Fonds
collaborator UNKNOWN - lead OTHER
Principal Investigators
-
Maarten J Titulaer, MD,PhD · Erasmus Medical Center
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-12-31
- Primary Completion
- 2019-12-31
- Completion
- 2020-12-31
Countries
- Netherlands
Study Locations
More Related Trials
-
Role of Antibodies Against Glutamate Receptors and Double Stranded DNA in Epilepsy Patients
NCT00317668 ·Status: UNKNOWN
-
Idiopathic Generalized Epilepsy Syndromes
NCT06388174 ·Status: RECRUITING
-
Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study
NCT00088452 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Eslicarbazepine Acetate Monotherapy in Subjects With Partial Epilepsy Not Well Controlled by Current Antiepileptic Drugs
NCT00866775 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal Epilepsy
NCT02495844 ·Status: COMPLETED ·Phase: PHASE2
-
Naturalistic Study to Evaluate the Utilization of Care Services Associated to the Diagnostic Process of Any Kind of Epilepsy
NCT00522522 ·Status: COMPLETED
-
Genetic Diagnosis and Personalized Medicine for Patients With Epilepsy
NCT06321822 ·Status: RECRUITING ·Phase: NA
-
Epilepsy Prevalence and Intervention Study in Zhejiang Province, China
NCT04944641 ·Status: UNKNOWN ·Phase: NA
-
Study to Improve the Treatment of Epilepsy (SITE)
NCT00133081 ·Status: UNKNOWN ·Phase: PHASE4
-
A Study to Evaluate the Efficacy, Safety, and Tolerability of Brivaracetam as Monotherapy in Patients 2 to 25 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
NCT04666610 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Clinical-genetic Investigations in Children With Early Infantile Epilepsies
NCT01357707 ·Status: COMPLETED
-
Multicentre Real-life Follow-up Study of Rare Epileptic Syndromes in Children and Adolescents
NCT05126914 ·Status: RECRUITING
-
Adjunctive Anti-seizure Medication (ASM) Real World Evidence (RWE) Study
NCT05867160 ·Status: ACTIVE_NOT_RECRUITING
-
Precision Medicine in the Treatment of Epilepsy
NCT05450822 ·Status: RECRUITING
-
Rolandic Epilepsy Genomewide Association International Study
NCT03547050 ·Status: COMPLETED
-
Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Lamotrigine.
NCT02283801 ·Status: COMPLETED ·Phase: PHASE1
-
Seizure Treatment in Glioma
NCT03048084 ·Status: RECRUITING ·Phase: PHASE4
-
Clinical Trial Data Set Re-use With Statistical Methodologies Tailored for Clinical Trials in Rare Diseases
NCT05199402 ·Status: COMPLETED
-
Assessment of Suicidality in Epilepsy - Rating Tools
NCT01085461 ·Status: COMPLETED
-
A Study for Evaluating the Efficacy and Safety of Zonisamide and Lamotrigine (Lamictal) for Subjects With Refractory Simple Partial, Complex Partial or Partial With Secondary Generalized Seizures
NCT00292461 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Tacrolimus and I.V.-Immunoglobulins in Rasmussen Encephalitis
NCT00545493 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Study for the Diagnosis and Treatment of Drug-resistant Focal Epilepsies
NCT06794606 ·Status: RECRUITING
-
Investigating Epilepsy: Screening and Evaluation
NCT03478852 ·Status: RECRUITING
-
Effect of the New Definition of Epilepsies of the ILAE of 2014 on the Diagnosis After the First Seizure
NCT06836687 ·Status: RECRUITING
-
A Study to Test the Long-term Safety, Tolerability and Efficacy of Brivaracetam in Study Participants 2 to 26 Years of Age With Childhood Absence Epilepsy or Juvenile Absence Epilepsy
NCT05109234 ·Status: COMPLETED ·Phase: PHASE3